Universite Paris Est, Faculte de medecine, Creteil, 94000, France.
Curr Psychiatry Rep. 2013 Sep;15(9):387. doi: 10.1007/s11920-013-0387-y.
Bipolar disorder is now known to be associated not only with highly prevalent co-occurring psychiatric and substance use disorders but also with medical comorbidities, such as cardiovascular diseases, diabetes mellitus, obesity and thyroid dysfunction. Inflammatory disturbances repeatedly observed in bipolar disorder, can explain some of the comorbidity between bipolar disorder and medical disorder. This revised perspective of bipolar disorders should promote the development of therapeutic tools. Immuno-inflammatory dysfunction may well represent a significant component of the underlying pathophysiology of the disorder. We therefore propose to review the immuno-inflammatory hypothesis in bipolar disorder considering the co-occurence with autoimmune diseases, immunological and inflammatory markers, as well as immuno-genetic markers which could lead to personalized treatments.
双相障碍现在不仅与普遍存在的共患精神和物质使用障碍有关,而且与心血管疾病、糖尿病、肥胖和甲状腺功能障碍等医学合并症有关。在双相障碍中反复观察到的炎症紊乱,可以解释双相障碍和医学障碍之间的一些共病关系。这种对双相障碍的修正观点应该促进治疗工具的发展。免疫炎症功能障碍很可能是该疾病潜在病理生理学的重要组成部分。因此,我们建议考虑到自身免疫性疾病、免疫和炎症标志物以及免疫遗传标志物的共病情况,从免疫炎症假说的角度来审查双相障碍,这可能会导致个性化治疗。